Translating Permeability Assays to Human Peff

Why Assay Permeability Needs Translation

A permeability assay measures movement across a particular experimental barrier under particular conditions. Human intestinal effective permeability, \(P_{\mathrm{eff,h}}\), is a model input representing transport across the human intestinal surface under in vivo conditions. These quantities are related, but they are not interchangeable: cell type, membrane area, hydrodynamics, unstirred water layers, and experimental geometry differ between assays and the human gut.

The earlier material on Effective Permeability and Intestinal Absorption established how \(P_{\mathrm{eff}}\) contributes to absorption in a PBPK model. Here the focus is translating measurements from Caco-2 cells, MDCK cells, and in situ intestinal perfusion into a defensible human estimate. The key principle is to translate a per-area permeability, not to multiply a cell-assay value by a gut-to-insert area ratio.

For an assay with membrane area \(A\), steady transfer rate \(dM/dt\), and approximately constant donor concentration \(C_D\), the standard calculation is

This form assumes that the measured receiver-side appearance represents transfer across the barrier, the donor concentration is an appropriate driving concentration, and the rate is estimated over a period in which transfer is approximately linear. If donor concentration falls substantially, using its initial value as though it remained constant can bias the estimate. Recovery, adsorption, leaks, and material retained in the apparatus should also be checked.

Area Normalization and Total Absorption

Area normalization makes a permeability coefficient independent of the area used in the assay calculation, provided the measured flux scales with area and the barrier is uniform. It does not mean that area is irrelevant to absorption. In a simplified concentration-driven model, total transfer rate depends on both permeability and exposed area:

Thus, multiplying a permeability coefficient by a surface-area ratio and calling the result a new permeability is generally a category error. Surface area belongs in the total conductance or absorption-rate calculation. It should enter a translation only if the model explicitly defines a different quantity, such as total permeability clearance.

The surface area used in a cell assay still matters: it must be the membrane area corresponding to the measured flux. An incorrect insert area directly biases \(P_{\mathrm{app}}\). In vivo, the relevant human area is an effective absorptive area, not automatically the geometric area of a smooth tube. Applying a large anatomical area multiplier to an assay permeability without considering how the PBPK model defines area can therefore double-count surface amplification.

Translating Caco-2 and MDCK Results

Caco-2 and MDCK assays are cell-monolayer systems, not miniature human intestine. Their measured \(P_{\mathrm{app}}\) can be useful for ranking compounds and informing human predictions, but a universal conversion factor is not justified. A practical approach is to calibrate the assay against reference compounds for which human \(P_{\mathrm{eff,h}}\) is available from an appropriate in vivo measurement or an accepted reference data set. Calibration compounds should span the test compound’s permeability range and should be measured with compatible assay protocols.

If a linear, through-origin relationship is supported over the relevant range, a simple calibration is

The ratio is an empirical assay-to-human scaling factor, not a biological constant. A fitted intercept may be needed if reference data support it, and nonlinear relationships may be needed across a broad range. Do not extrapolate a calibration far beyond its measured range. Caco-2 and MDCK values should generally be calibrated separately because cell line, culture conditions, and assay configuration can affect the relationship.

Unstirred Water Layers as Serial Resistances

A compound may cross an aqueous unstirred water layer (UWL) before reaching a cell surface and another aqueous layer on the receiver side. When each layer and the cell barrier are at steady state, and the same flux passes through each in series, their resistances add. If \(P_{\mathrm{mem}}\) denotes membrane permeability and \(P_{\mathrm{UWL}}\) denotes the effective permeability of the combined aqueous-layer resistance, then

This equation explains why the measured value cannot exceed either limiting permeability. It also shows why the correction is unstable when \(P_{\mathrm{app}}\) is close to \(P_{\mathrm{UWL}}\): a small measurement error can produce a large change in the inferred membrane permeability.

A UWL correction is only as sound as its estimate of \(P_{\mathrm{UWL}}\), which can depend on stirring, well geometry, solubility, and compound properties. If the correction implies \(P_{\mathrm{app}}\geq P_{\mathrm{UWL}}\), the assumptions or measurements are inconsistent; the algebra would imply a nonpositive or undefined membrane resistance. It is usually safer to report the measured \(P_{\mathrm{app}}\), the correction assumptions, and the corrected estimate separately.

Deriving Permeability From In Situ Perfusion

In a simplified single-pass intestinal perfusion experiment, fluid flows at rate \(Q\) through a segment with radius \(r\) and length \(L\). Assume steady plug flow, a well-mixed lumen cross-section, constant segment geometry, no net water flux (or concentrations corrected for it), and first-order loss from the lumen to the wall. The segment’s cylindrical surface area is \(2\pi rL\). Under these conditions, the outlet-to-inlet concentration ratio yields an area-normalized effective permeability:

This estimate already reflects the experimental species, intestinal segment, perfusion conditions, and the surface-area convention used in the calculation. It is not automatically the human value. A species translation should use matched reference compounds or another justified cross-species calibration, rather than assuming that a rat or other animal estimate equals human \(P_{\mathrm{eff,h}}\).

Choosing a Translation and Diagnosing Failure

The appropriate approach depends on what the assay controls and what reference information is available. Cell assays offer controlled comparison across compounds, but their translation depends strongly on assay-specific calibration. In situ perfusion samples an intact intestinal segment and can provide a direct segment-level effective estimate, but it remains species- and protocol-dependent. Neither approach is universally superior.

Before accepting a translated value, check whether flux was linear over the measurement window, whether mass recovery was adequate, whether the monolayer was intact, and whether the test and reference compounds were run under compatible conditions. For in situ estimates, verify flow and segment dimensions, check for meaningful water absorption or secretion, and confirm that the measured outlet concentration is above the quantification limit. Unexpectedly high values can arise from barrier leakage or an incorrect area; very low values can reflect poor recovery, unstable compound, or assay limitations rather than genuinely low human permeability.

A further warning is that UWL resistance and calibration are not interchangeable corrections. The UWL equation estimates how much an aqueous boundary layer depresses an assay result under its assumptions. A reference-compound calibration maps the entire assay result to human values and can implicitly absorb several assay-specific differences. Applying a UWL correction and then applying a calibration developed on uncorrected measurements can count the same discrepancy twice. The correction status of the calibration data must be explicit.

These methods also have limits. A one-point reference ratio cannot establish that a relationship is linear across all compounds. Assay-to-human predictions inherit uncertainty from measured flux, area, concentration, calibration data, and model assumptions. A single scalar \(P_{\mathrm{eff,h}}\) is a simplified representation; its appropriateness depends on the PBPK model’s intended use and area conventions. Permeability assays alone do not establish all processes affecting oral availability, so a translated value should not be interpreted as a complete explanation of absorption or systemic exposure.

Common Pitfall

Wrong reasoning: “The human intestine has a much larger surface area than a cell insert, so I will multiply the Caco-2 \(P_{\mathrm{app}}\) by the ratio of those areas to obtain human \(P_{\mathrm{eff}}\).”

Correction: \(P_{\mathrm{app}}\) is already normalized by assay area. Translate it to a human per-area permeability using appropriate calibration or a justified model. Then use the PBPK model’s human effective area when calculating total permeability conductance or absorption rate. Multiplying the coefficient by area and later multiplying again by human area overstates absorption.